CClinicalTrials.gg
Not yet recruitingNCT06215417HDA v RegenUpdated Jan 22, 2024

Rotator Cuff Augmentation With Human Dermal Allograft Versus Bovine Collagen Xenograft Patch: A Randomized Controlled Trial

A Phase 4 interventional study of Rotator cuff repair in Rotator Cuff Tears, sponsored by University of Calgary. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-22.

Sponsored by University of Calgary · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized controlled trial comparing human dermal allograft with bovine collagen xenograft in rotator cuff repair.

Read the detailed description

Randomized controlled trial comparing human dermal allograft with bovine collagen xenograft in rotator cuff repair.

Subjects will be randomized intraoperatively after confirmation of inclusion criteria.

Subjects will be followed-up at 3 weeks, 3 months, 6 months, 12 months and 24 months post-operatively.

Primary outcome is Western Ontario Rotator Cuff Index (WORC) at 12 months. Additional outcomes include American Shoulder and Elbow Surgeons questionnaire (ASES), Single Numeric Evaluation (SANE) score, EuroQoL (5 domains) score (a quality of life score), and Visual Analogue Scale, healing rate as determined by Magnetic Resonance Imaging (MRI) scan at 12 months post surgery. To determine the cost utility, data will be collected on the cumulative cost for the total episode of care up to 12 months post surgery inclusive of surgical costs, implant costs, outpatient costs, and medication costs. Quality-Adjusted Life Years (QALYs) gained will be calculated using the mean total cost and the quality of life score (EQ-5D) improvement from pre-operative to 12 months post surgery.

02

Conditions studied

  • Rotator Cuff Tears

Browse trials for

03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's planned enrollment of 102 is above the median of 60 across 538 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

University of Calgary is the lead sponsor of 686 studies on the registry; 189 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

>18 years

  • fully reparable full thickness rotator cuff tear whereby the treating surgeon feels a graft augment is needed to enhance healing

Exclusion criteria

Exclusion Criteria:

  • tears where only a partial repair is achieved
  • significant glenohumeral joint arthropathy (Hamada grade 2 and above)
  • irreparable rotator cuff tears
  • patients unable or unwilling to consent or comply with study questionnaires
  • patients with upper limb neurological deficits affecting the ipsilateral limb
  • workers compensation cases
  • cases involving litigation
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
102 participants (estimated)

Study arms

  • Experimental
    HDA

    Human dermal allograft (LifeNet Health Arthroflex graft)

    Procedure: Rotator cuff repair

  • Active comparator
    Regeneten

    Bovine collagen patch xenograft (Smith \& Nephew Regeneten)

    Procedure: Rotator cuff repair

Interventions

  • ProcedureRotator cuff repair

    Arthroscopic rotator cuff repair augmented with graft.

06

What researchers measure

Primary outcomes

  1. Western Ontario Rotator Cuff Index (WORC)

    rotator cuff quality of life outcome questionnaire

    Time frame: 12 mos post-op

Secondary outcomes

  1. Western Ontario Rotator Cuff Index (WORC)

    rotator cuff quality of life outcome questionnaire

    Time frame: pre-op, 3 mos, 6 mos, 24 mos post-op

  2. Single Assessment Numeric Evaluation (SANE)

    numeric score indicating shoulder assessment

    Time frame: pre-op, 3mos, 6mos, 12mos, 24mos post-op

  3. EuroQOL5D

    general health assessment score

    Time frame: pre-op, 3mos, 6mos, 12mos, 24mos post-op

  4. Shoulder pain assessed by visual analog scale (VAS)

    assessment of shoulder pain

    Time frame: pre-op, 3mos, 6mos, 12mos, 24mos post-op

  5. Anatomic healing

    anatomic healing as assessed via MRI

    Time frame: 12mos post-op

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — No sharing of IPD.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06215417
Lead sponsor
University of Calgary
Responsible party
Sponsor
First posted
Jan 22, 2024
Start date
Mar 2024 (estimated)
Primary completion
Sep 2028 (estimated)
Completion
Dec 2029 (estimated)
Last update
Jan 22, 2024

Study contacts

Kristie More, MSc
Contact
kristie.more@ucalgary.ca
14032208954

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion